CompletedNCT02427217
An Observational Cohort Study of the Safety and Efficacy of Fibrinogen Concentrate, Human (FCH) in Subjects With Congenital Fibrinogen Deficiency
Studying Congenital fibrinogen deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- CSL Behring
- Principal Investigator
- Program DirectorCSL Behring
- Intervention
- FCH(biological)
- Enrollment
- 22 enrolled
- Eligibility
- All sexes
- Timeline
- 2015 – 2017
Study locations (10)
- Study Site, Aurora, Colorado, United States
- Study Site, Las Vegas, Nevada, United States
- Study Site, Durham, North Carolina, United States
- Study Site, Calgary, Alberta, Canada
- Study Site, Edmonton, Alberta, Canada
- Study Site, Winnipeg, Manitoba, Canada
- Study Site, Halifax, Nova Scotia, Canada
- Study Site, Hamilton, Ontario, Canada
- Study Site, Toronto, Ontario, Canada
- Study Site, Montreal, Quebec, Canada
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02427217 on ClinicalTrials.govOther trials for Congenital fibrinogen deficiency
Additional recruiting or active studies for the same condition.